Inventor
KARL TRYGGVASON
Inventor
SG
Overview
Patents· 7 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
C12Nprimary
C12NMicroorganisms or enzymes58%
A61KPreparations for medical, dental or toiletry purposes25%
C12PFermentation or enzyme-using processes to synthesise a desired chemical compound or composition or to separate optical isomers from a racemic mixture8%
C12QMeasuring or testing processes involving enzymes, nucleic acids or microorganisms8%
PatentTitleYear
12,391,915Maintenance of differentiated cells with laminins202512,378,527Differentiation of pluripotent stem cells using laminins LN-511, LN-521 and LN-221202512,221,624Systems and methods for producing retinal progenitors202512,195,757Methods of producing RPE cells202511,767,509Methods of producing RPE cells202311,655,451Methods for culturing human keratinocytes202311,155,781Maintenance of differentiated cells with laminins2021Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2021–2025Patents assigned to BIOLAMINA AB (5)· patent assignee history
2021–2025Based in SG· patent location history
2023–2025Patents assigned to NAT UNIV SINGAPORE (3)· patent assignee history
2023Patents assigned to SINGAPORE HEALTH SERV PTE LTD (1)· patent assignee history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| BIOLAMINA AB | 5 | 2021–2025 |
| NAT UNIV SINGAPORE | 3 | 2023–2025 |
| SINGAPORE HEALTH SERV PTE LTD | 1 | 2023 |
Locations
| Location | Patents | Span |
|---|---|---|
| SG | 7 | 2021–2025 |